[Fibrate and its perspective as a drug for metabolic syndrome].
Tada
Norio
N
Division of General Medicine, Department of Internal Medicine, The Jikei University, Kashiwa Hospital.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002995:Clofibric Acid / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000188:drug therapy*
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D002995:Clofibric Acid